Načítá se...
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
BACKGROUND: Coronavirus disease 19 (COVID-19) is a novel disease entity that is spreading throughout the world. It has been speculated that patients with comorbidities and elderly patients could be at high risk for respiratory insufficiency and death. Immunosuppression could expose infected patients...
Uloženo v:
| Vydáno v: | Mult Scler Relat Disord |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier B.V.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7156942/ https://ncbi.nlm.nih.gov/pubmed/32315980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.msard.2020.102120 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|